I'm a bit confused by the timing of this. Here's a press release from only a couple months ago, in which a Moderna partnership on an mRNA vaccine showed some benefit in macaques, but mostly in delaying infection (i.e. most macaques in the treatment group still got SHIV). Only two of seven in the treatment group actually remained uninfected. It sounded like researches wanted to refine and validate their protocol before moving to human trials.
> “We are now refining our vaccine protocol to improve the quality and quantity of the VLPs produced. This may further increase vaccine efficacy and thus lower the number of prime and boost inoculations needed to produce a robust immune response. If confirmed safe and effective, we plan to conduct a Phase 1 trial of this vaccine platform in healthy adult volunteers,” said Dr. Lusso.
I interpreted "If confirmed safe and effective" to mean that more animal tests would happen.
https://www.nih.gov/news-events/news-releases/experimental-m...